Medy-Tox Inc.
Biopharmaceutical firm developing botulinum toxins, HA fillers, and dermocosmetics.
086900 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086900008
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청원군 오창읍 각리1길 78 (주)메디톡스, 청원군
- Sector:
- Manufacturing
Description
Medy-Tox Inc. is a biopharmaceutical company focused on the research, development, and commercialization of biologic products. Its primary offerings are centered on botulinum toxin type A (BTX-A) formulations, including Neuronox®, INNOTOX®, Coretox®, and NEWLUX®, which are used for both aesthetic and therapeutic applications. The company is noted for developing the world's first liquid-injectable botulinum toxin. In addition to its toxin portfolio, Medy-Tox manufactures and markets a line of hyaluronic acid (HA) dermal fillers, such as Neuramis®, Atiere, and Potenfill. The company's product range also extends to dermocosmetics under the NEURADERM brand.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-10-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2020-10-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.8 KB | ||
| 2020-10-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2020-10-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2020-10-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2020-10-28 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 170.4 KB | ||
| 2020-10-27 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.6 KB | ||
| 2020-10-26 00:00 |
[기재정정]주주명부폐쇄기간또는기준일설정
|
Korean | 9.0 KB | ||
| 2020-10-22 00:00 |
증권발행실적보고서
|
Korean | 36.1 KB | ||
| 2020-10-22 00:00 |
불성실공시법인지정예고(공시번복)
|
Korean | 5.3 KB | ||
| 2020-10-21 00:00 |
권리락(무상증자)
|
Korean | 3.7 KB | ||
| 2020-10-21 00:00 |
[기재정정]주요사항보고서(유무상증자결정)
|
Korean | 22.5 KB | ||
| 2020-10-21 00:00 |
[기재정정]권리락(무상증자)
|
Korean | 7.6 KB | ||
| 2020-10-21 00:00 |
기타경영사항(자율공시)(유상증자 중단으로 인한 신주인수권증서 매수 보상)
|
Korean | 6.4 KB | ||
| 2020-10-21 00:00 |
기타주요경영사항(주요사항보고서(유무상증자 발행결정)철회)
|
Korean | 6.4 KB |
Automate Your Workflow. Get a real-time feed of all Medy-Tox Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medy-Tox Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medy-Tox Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
